Secukinumab tablet - Scapho | Blueberrypharmaceuticals

SECUKINUMAB

It is indicated for the treatment of patients with Plaque Psoriasis.

It is used to treat psoriasis, ankylosing spondylitis, and psoriatic arthritis It is given by subcutaneous..

injection and is sold in a pre-filled syringe or autoinjector that can be used at home and as a lyophilized powder for use in hospitals and clinics.

Indication

Scapho indicated for the treatment of following condition :

1.Psoriatic arthritis,

2.Plaque Psoriasis,

3.Ankylosing spondylitis.

Medication Prescribed For ;

Secukinumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red,

 scaly patches form on some areas of the body) in people whose psoriasis is too severe to be treated by topical medications alone.

Mechanism of Action : 

Human IgG1 monoclonal antibody which selectively joins to and negate the pro inflammatory cytokine interleukin 17A (IL-17A)

IL-17A is a normallyappearing cytokine which is involved in normal inflammatory and immune responses and plays a key role 

in the pathogenesis of plaque psoriasis.

Precautions : 

Scapho may increase risk of infections; use with caution in patients with chronic infection or a history of recurrent infection 

Start with anti-TB therapy before to initiation of Secukinumab in patients with a history of latent or active TB in whom

an adequate course of treatment cannot be confirmed..

For More Infomation :

Call us :  +91-97890 77748
Mail to :  info@blueberrypharma.com
Domain : https://blueberrypharma.com/secukinumab.php